247 related articles for article (PubMed ID: 25378241)
1. F3-Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegans.
Nguyen TT; Aschner M
Curr Protoc Toxicol; 2014 Nov; 62():11.17.1-13. PubMed ID: 25378241
[TBL] [Abstract][Full Text] [Related]
2. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid.
Gao L; Yin H; Milne GL; Porter NA; Morrow JD
J Biol Chem; 2006 May; 281(20):14092-9. PubMed ID: 16569632
[TBL] [Abstract][Full Text] [Related]
3. Isoprostanes.
Roberts LJ; Milne GL
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S219-23. PubMed ID: 18957694
[TBL] [Abstract][Full Text] [Related]
4. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry.
Milne GL; Gao B; Terry ES; Zackert WE; Sanchez SC
Free Radic Biol Med; 2013 Jun; 59():36-44. PubMed ID: 23044261
[TBL] [Abstract][Full Text] [Related]
5. Quantification of in vivo oxidative damage in Caenorhabditis elegans during aging by endogenous F3-isoprostane measurement.
Labuschagne CF; Stigter EC; Hendriks MM; Berger R; Rokach J; Korswagen HC; Brenkman AB
Aging Cell; 2013 Apr; 12(2):214-23. PubMed ID: 23279719
[TBL] [Abstract][Full Text] [Related]
6. Measurement of isoprostanes as markers of oxidative stress.
Milatovic D; Montine TJ; Aschner M
Methods Mol Biol; 2011; 758():195-204. PubMed ID: 21815067
[TBL] [Abstract][Full Text] [Related]
7. Increased F3-Isoprostanes in the Canadian Inuit Population Could Be Cardioprotective by Limiting F2-Isoprostane Production.
Alkazemi D; Jackson RL; Chan HM; Kubow S
J Clin Endocrinol Metab; 2016 Sep; 101(9):3264-71. PubMed ID: 27192695
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution.
Davis TA; Gao L; Yin H; Morrow JD; Porter NA
J Am Chem Soc; 2006 Nov; 128(46):14897-904. PubMed ID: 17105300
[TBL] [Abstract][Full Text] [Related]
9. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
[TBL] [Abstract][Full Text] [Related]
10. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method.
Liu W; Morrow JD; Yin H
Free Radic Biol Med; 2009 Oct; 47(8):1101-7. PubMed ID: 19647073
[TBL] [Abstract][Full Text] [Related]
11. The isoprostanes--25 years later.
Milne GL; Dai Q; Roberts LJ
Biochim Biophys Acta; 2015 Apr; 1851(4):433-45. PubMed ID: 25449649
[TBL] [Abstract][Full Text] [Related]
12. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids.
Vigor C; Bertrand-Michel J; Pinot E; Oger C; Vercauteren J; Le Faouder P; Galano JM; Lee JC; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():65-78. PubMed ID: 24856297
[TBL] [Abstract][Full Text] [Related]
13. Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid.
Brooks JD; Milne GL; Yin H; Sanchez SC; Porter NA; Morrow JD
J Biol Chem; 2008 May; 283(18):12043-55. PubMed ID: 18263929
[TBL] [Abstract][Full Text] [Related]
14. Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress.
Musiek ES; Morrow JD
Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.6. PubMed ID: 23045115
[TBL] [Abstract][Full Text] [Related]
15. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans.
Arneson KO; Roberts LJ
Methods Enzymol; 2007; 433():127-43. PubMed ID: 17954232
[TBL] [Abstract][Full Text] [Related]
16. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.
Milatovic D; Aschner M
Curr Protoc Toxicol; 2009 Feb; Chapter 12(Supplement 39):Unit12.14. PubMed ID: 20191108
[TBL] [Abstract][Full Text] [Related]
17. Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?
Roy J; Le Guennec JY; Galano JM; Thireau J; Bultel-Poncé V; Demion M; Oger C; Lee JC; Durand T
Biochimie; 2016 Jan; 120():56-61. PubMed ID: 26112019
[TBL] [Abstract][Full Text] [Related]
18. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.
Leung KS; Galano JM; Durand T; Lee JC
Free Radic Res; 2015; 49(7):816-26. PubMed ID: 25184341
[TBL] [Abstract][Full Text] [Related]
19. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
Yen HC; Wei HJ; Lin CL
Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
[TBL] [Abstract][Full Text] [Related]
20. Quantification of F2-isoprostanes as a biomarker of oxidative stress.
Milne GL; Sanchez SC; Musiek ES; Morrow JD
Nat Protoc; 2007; 2(1):221-6. PubMed ID: 17401357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
